Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK

E. L. Newman, A. Borsodi, G. Toth, F. Hepp, E. A. Barnard

Research output: Contribution to journalArticle

12 Citations (Scopus)


A novel affinity reagent DALECK, i.e. D-Ala2-Leu5-enkephalin with a C-terminal chloromethyl ketone group, was previously synthesized in normal and in tritiated form and shown to react irreversibly at opioid receptors, with some evidence for selectivity for the μ subtype. DALECK tritiated in its phenolic group has been synthesized at 13-fold higher specific radioactivity than in the previous study. In the irreversible reaction of this product at pH 8.1 with rat brain membranes it was confirmed that only one polypeptide there is labelled, of apparent Mr 58,000. Competition between this reaction and ligands highly selective for the μ, δ or κ binding sites yielded curves demonstrating the very high selectivity of the DALECK irreversible reaction for the μ site. The results provide evidence that the μ opioid receptor protein contains only one type of binding subunit, whose apparent Mr is 58,000, this size being dependent upon the conditions used in the gel electrophoresis and being higher when stringent conditions which would reduce all internal disulphide bonds are applied.

Original languageEnglish
Pages (from-to)305-315
Number of pages11
Issue number4
Publication statusPublished - Jan 1 1986

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Mu-receptor specificity of the opioid peptide irreversible reagent, [<sup>3</sup>H] DALECK'. Together they form a unique fingerprint.

  • Cite this